Acumen Pharmaceuticals Q2 net loss widens
Overview
Acumen Q2 net loss widens to $41.0 mln, driven by increased R&D expenses
Cash reserves of $166.2 mln expected to support operations into early 2027
Outlook
Cash reserves expected to support operations into early 2027
Result Drivers
SCREENING INNOVATIONS - Co implemented a two-step screening process in ALTITUDE-AD phase 2 clinical trial, reducing costs by 40% across U.S. and Canadian sites and improving enrollment rates
R&D EXPENSES - Increased R&D expenses driven by manufacturing and materials costs for ALTITUDE-AD trial
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Net Income |
| -$40.95 mln |
|
Q2 Basic EPS |
| -$0.68 |
|
Q2 Income From Operations |
| -$41.75 mln |
|
Q2 Operating Expenses |
| $41.75 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the biotechnology & medical research peer group is "buy."
Wall Street's median 12-month price target for Acumen Pharmaceuticals Inc is $10.00, about 85.8% above its August 11 closing price of $1.42
Press Release: ID:nGNX6js0Qq
Related Articles
Bridgewater Associates Q2 2025 13F Analysis: Founder Ray Dalio’s Final Act
TradingKey - Bridgewater Associates, the world’s largest hedge fund and renowned for its macroeconomic analysis, continues to command market respect with its “risk parity” strategy and precise economic cycle timing..jpg)
Investing in Quantum Computing
TradingKey - What was once confined to university labs and science fiction books is now becoming one of the most disruptive technologies of the next twenty years, set to transform industries from pharmaceuticals and materials science to finance, logistics, and climate modeling.
U.S. July CPI Commentary: Obstacles Cleared, Where Will U.S. Stocks Go Next?
TradingKey - On 12 August 2025, the United States released its Consumer Price Index (CPI) data for July. In terms of headline inflation, the CPI rose by 2.7% year-on-year in the month, slightly lower than the expected 2.8%. However, core CPI climbed 3.1% year-on-year, edging past the projected 3.0%.
Ethereum Price Prediction: Will ETH Extend the Rally? What’s the Future Trend?
Ethereum's impressive 2025 rally has been largely fueled by inflows from spot ETFs and a surge in institutional holdings, signaling growing confidence in its role as a core asset in the crypto market. However, to officially confirm the start of a new bull cycle, ETH must break above the critical $4,
